ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
18 hedge funds and large institutions have $2.18M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 19 → 18 (-1)
20% less capital invested
Capital invested by funds: $2.74M → $2.18M (-$558K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$23.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.36K |
| 3 |
LYV
Live Your Vision
West Conshohocken,
Pennsylvania
|
+$1.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$292K |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$58K |
| 3 |
Goldman Sachs
New York
|
-$5.03K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$4.58K |
| 5 |
PM
Platinum Management
New York
|
-$4.3K |
ECTE Hedge Fund Activity: Q3 2015 in Review
18 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q3 2015, worth a combined $2.18M — down 20% from $2.74M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ECTE and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $23.3K. The largest seller was HighTower Advisors, cutting an estimated $292K.
- 18 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q3 2015, down from 19 in Q2 2015.
- Funds reported $2.18M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q3 2015, down 20% quarter-over-quarter.
- 2 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q3 2015 and 3 closed out, a net change of -1 holder.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q3 2015 was Citadel Advisors, an estimated $23.3K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q3 2015 was HighTower Advisors, an estimated $292K sold.
Based on aggregated 13F filings for Q3 2015.